Melline G.M. Schilham

Papers

Total Citations

H-Index

About

Melline G.M. Schilham is a leading researcher in the field of urologic oncology, with a primary focus on improving outcomes for prostate cancer patients through advanced imaging. Her work centers on the clinical application of PSMA-PET/CT, a cutting-edge molecular imaging technique, to refine surgical planning and prognostication. In her most-cited study, "Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection" (2021, 29 citations), Schilham demonstrated that preoperative PSMA-PET/CT findings can independently predict biochemical persistence and early recurrence after radical prostatectomy with lymph node dissection. This contribution has significant clinical implications, enabling more personalized risk stratification and potentially guiding adjuvant therapy decisions. Her research bridges the gap between advanced imaging and surgical oncology, offering a non-invasive tool to identify high-risk patients before surgery. With 29 citations on this pivotal paper, Schilham’s work is gaining traction in the urology and nuclear medicine communities, positioning her as an emerging authority in precision medicine for prostate cancer. Her findings underscore the value of integrating molecular imaging into standard preoperative workflows to improve long-term patient outcomes.